Non-invasive Detection of HER2 Expression by Al18F-NOTA-HER2 Affibody in Gastric Cancer Xenografts

被引：0
|
作者：
Han, Jingya [1 ]
Zhao, Xinming [1 ]
Chen, Yang [1 ]
Zhang, Jingmian [1 ]
Wang, Jianfang [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Dept Nucl Med, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1081
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of HER2/neu expression in gastric cancer
    Ananiev, Julian
    Gulubova, Maya
    Manolova, Irena
    Tchernev, Georgi
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (13-14) : 450 - 454
  • [32] Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer
    Xiong, Zhongtang
    Liu, Kai
    Liu, Shaoyan
    Feng, Jiahao
    Wang, Jin
    Feng, Zewen
    Lai, Boan
    Zhang, Qingxin
    Jiang, Qingping
    Zhang, Wei
    BMC CANCER, 2024, 24 (01)
  • [33] Detection and HER2 expression of circulating tumor cells in advanced gastric cancer patients
    Matsusaka, Satoshi
    Chin, Keisho
    Ogura, Mariko
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Sano, Takeshi
    Yamaguchi, Toshiharu
    Yamamoto, Noriko
    Ishikawa, Yuichi
    Mishima, Yuji
    Terui, Yasuhito
    Hatake, Kiyohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] DETECTION AND HER2 EXPRESSION OF CIRCULATING TUMOR CELLS IN ADVANCED GASTRIC CANCER PATIENTS
    Matsusaka, S.
    Chin, K.
    Ogur, M.
    Shinozaki, E.
    Suenaga, M.
    Mizunuma, N.
    Sano, T.
    Yamaguchi, T.
    Hatake, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 118 - 118
  • [35] Expression of Her2/neu in gastric adenocarcinomas
    Batistatou, A.
    Lampri, E.
    Kamina, S.
    Malamou-Mitsi, V.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 251 - 252
  • [36] ER and HER2 Expression Are POSITIVELY Correlated in HER2 Non-Over Expressing Breast Cancer
    Pinhel, I
    Hills, M.
    Drury, S.
    Salter, J.
    Johnson, L.
    Barrett-Lee, P.
    Harris, A.
    Dowsett, M.
    CANCER RESEARCH, 2009, 69 (24) : 524S - 524S
  • [37] A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients
    Guo, Xiaoyi
    Zhou, Nina
    Ding, Jin
    Wang, Shuailiang
    Zhu, Hua
    Yang, Zhi
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S49 - S49
  • [38] Molecular imaging of HER2 expression using a multifunctional Affibody molecule
    Tran, T. A.
    Rosik, D.
    Abrahmsen, L.
    Sandstrom, M.
    Sjoberg, A.
    Wallberg, H.
    Ahlgren, S.
    Orlova, A.
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S233 - S233
  • [39] HER2 positive gastric cancer: Who benefits from HER2 targeted therapy?
    Kolbe, K.
    Haffner, I.
    Schierle, K.
    Maier, D.
    Geier, B.
    Luber, B.
    Kretzschmar, A.
    von Weikersthal, Fischer L.
    Ahlborn, M.
    Riera, J.
    Rau, B.
    Siegler, G.
    Fuxius, S.
    Decker, T.
    Wittekind, C.
    Lordick, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 156 - 157
  • [40] Correlation between Her2 expression and clinicopathological features of invasive gastric carcinoma
    Cozaru, G. C.
    Aschie, M.
    Mitroi, A. F.
    Baltatescu, G. I.
    Nicolau, A. A.
    Poinareanu, I.
    VIRCHOWS ARCHIV, 2014, 465 : S146 - S146
12345